Introduction
Birch trees, Betula, grow in the temperate climate zone of the northern hemisphere and release large amounts of pollen during spring. Exposure to birch pollen allergens is a major reason of allergic rhinitis in Europe and one of the most frequent triggers of respiratory disease among European patients (Eriksson et al., 1998; Kampe et al., 2010; Caillaud et al., 2014) . Birch pollen allergy and sensitization have not been as well studied in China mainly due to lack of specific diagnostic reagents. The major allergen of birch pollen is a 17-kDa protein called Bet v 1 (Ipsen and Løwenstein, 1983; Gajhede et al., 1996) . Although European birch allergic patients may occasionally react to other allergens, in birch-rich areas of Scandinavia over 95% of birch pollen allergic patients display immunoglobulin E (IgE)-binding to Bet v 1, while over 60% react exclusively to this allergen (Movérare et al., 2002) .
Up to 70% of birch pollen allergic individuals who experience seasonal rhinoconjunctivitis and/or asthma report having mucosal symptoms after consuming raw fruits and vegetables (Hofmann and Burks, 2008) . The symptoms from this so called pollen-food allergy syndrome are often mild and self-resolving (Ma et al., 2003) . However, severe systemic effects have been reported and can occur upon food consumption outside the pollen season (Katelaris, 2010; Rashid et al., 2011) . The immunologic basis for the clinical reactions is considered to be due to cross-reacting IgE antibodies that are specific to birch pollen allergens, in particular Bet v 1, but that can also recognize Bet v 1-homologous allergens from fruits and vegetables (Holm et al., 2001; Mittag et al., 2004; Tolkki et al., 2013) . In a study evaluating severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1-related protein in soy bean (Glycine max), Gly m 4/SAM22, immediate-type allergic symptoms in patients with birch pollen allergy after ingestion of soy proteincontaining food items were reported to occur (KleineTebbe et al., 2002) .
Birch pollen sensitization and pollen-food allergy syndrome are believed to be common in northern China. However, due to the lack of diagnostic tools and specific reagents, the prevalence of birch pollen sensitization has seldom been reported and the specific IgE correlation between birch pollen and food/vegetable allergens in China has not been investigated in detail. In this retrospective study, we investigated the prevalence and correlations of birch pollen extract and major birch allergen sensitization as well as the specific IgE correlation with the major apple allergen Mal d 1 and soy bean allergen Gly m 4. The study was performed using sera collected from allergic patients in the city of Tangshan (China).
Materials and methods
There were 203 subjects included in this study (5-66 years old) with a clinical history of allergic rhinitis/asthma. The subjects attended the Department of Allergy, Tangshan Gongren Hospital (Tangshan, China), from February to July 2014. The city of Tangshan is approximately 149 km east by southeast of Beijing with a population of 7.5 million inhabitants located in the northeastern Hebei Province. All subjects donated blood for specific IgE tests and serum samples were stored at −20 °C before measurement. All subjects or guardians provided informed consent.
Specific IgE concentrations against birch pollen extract Bet v and major birch pollen allergen Bet v 1 were measured using the ADVIA Centaur (Siemens Medical Solutions, Diagnostics, NY, USA). The allergens, calibrators, controls, and universal reagent packs were from ALK (Hørsholm, Denmark). Major apple recombinant allergen rMal d 1 and soy bean recombinant allergen rGly m 4 specific IgE were measured by the ImmunoCAP 100 fluorescence enzyme immunoassay system (Thermo Fisher, Uppsala, Sweden). The Centaur system was calibrated against ImmunoCAP. The specific IgE results of ADVIA Centaur and ImmunoCAP 100 have been shown to be comparable (Petersen et al., 2004) . A cut-off value of 0.35 kU/L for specific IgE was regarded as a positive result (<0.35 kU/L, Class 0; 0.35-0.7 kU/L, Class 1; 0.7-3.5 kU/L, Class 2; 3.5-17.5 kU/L, Class 3; 17.5-50 kU/L, Class 4; 50-100 kU/L, Class 5; >100 kU/L, Class 6).
The linear regression was plotted and P-value was calculated at 95% confidence intervals using Graph Pad Prism Version 6.00 (GraphPad Software, Inc., USA).
Results
A total of 203 serum samples collected during the period February to July, 2014 were retrospectively tested for specific IgE against Bet v and Bet v 1. Among the 203 sera, 34 sera (16.7%) had specific IgE to Bet v and of these, 28 sera (82.4%) contained Bet v 1-specific IgE (Table 1 ). The majority of birch allergen sera had specific IgE levels corresponding to ImmunoCAP Classes 3 and 4 ( Fig. 1) and were detected in sera from patients attending the clinic during the birch pollen season (April to May). The correlation of specific IgE between Bet v and Bet v 1 was high (P<0.0001, R 2 =0.98). All patients' sera with specific IgE to Bet v 1 had specific IgE antibodies against Bet v. Only 6 patients (17.6%) with Bet vspecific IgE were negative to Bet v 1. Three of these sera had Bet v-specific IgE of Class 3 and the other three had specific IgE of Classes 1 and 2.
To investigate the relation between Bet v 1 and apple allergen, Mal d 1 sensitization, specific IgE against recombinant Mal d 1 was measured in the 28 samples positive to Bet v 1 and in an additional 37 samples negative to Bet v 1. Of the 28 serum samples containing Bet v 1-specific IgE, 27 samples (96.4%) also contained rMal d 1-specific IgE with a highest level of 34.4 kUA/L. All Bet v 1-negative samples were also negative to rMal d 1-specific IgE. In the same serum sample, the rMal d 1-specific IgE level was never higher than the level of Bet v 1-specific IgE. There was a high correlation between Bet v 1 and rMal d 1-specific IgE (P<0.0001, R 2 =0.78; Fig. 2a ). Likewise, to investigate the relation between Bet v 1 and soy bean allergen Gly m 4 sensitization, specific IgE against rGly m 4 was measured in the 28 samples positive to Bet v 1 and in the 37 samples negative to Bet v 1. Of the 28 serum samples containing Bet v 1-specific IgE, 22 samples (78.6%) also contained rGly m 4-specific IgE with a highest level of 28.2 kUA/L. All Bet v 1-negative samples were also negative to rGly m 4 IgE. In the same serum sample, the rGly m 4-specific IgE level was never higher than 
Discussion
In a nationwide, year-long study, the skin prick test (SPT) prevalence of tree pollen, including Bet v, sensitization among 6304 Chinese allergic patients was reported to be 2% (Li et al., 2009 ). Geographical differences exist and the SPT prevalence is 4% in northern parts of China and 2.7% in the south (Li et al., 2009; Hong et al., 2011) . However, as demonstrated in this work, during the birch pollen season about 16.7% of the patients attending the allergy department in Tangshan City, northern China showed specific IgE-positive reaction to birch pollen allergens. This is in agreement with a previous study from this geographical area showing a prevalence of birch pollen-induced allergic rhinitis of 15%-22% (Wang et al., 2012) .
In this study, 82.4% of birch pollen sensitized patients also showed IgE-binding to Bet v 1 defining Bet v 1 as the major birch pollen allergen among the Chinese population. There were also 17.6% of birch pollen-sensitized subjects that did not show any specific IgE-binding to Bet v 1. This may be due to sensitization towards other minor birch allergens, for instance Bet v 2. Specific IgE-binding to Bet v 2 with a prevalence of around 2% has previously been demonstrated by allergen micro-array analyses of 100 Chinese allergic sera (Zheng et al., 2011) .
The first food allergen extract reported to show cross-reactivity to birch pollen was apple extract (Lahti et al., 1980) and it has been shown that around 28% patients with allergic rhinitis and monosensitized to birch pollen experience symptoms of pollen-food allergy upon consumption of apple (Tolkki et al., 2013) . The amino acid sequences of the major allergens Bet v 1 and the homologous apple allergen Mal d 1 are close to 50% identical (Holm et al., 2001) . The molecular structures of Bet v 1 and Mal d 1 are very similar, resulting in the appearance of common IgE-binding epitopes (Schöning et al., 1996; Holm et al., 2011) . In addition, birch pollen and apple share other homologous minor allergens with relatively low prevalence of specific IgE sensitization (Hauser et al., 2010) . We investigated Mal d 1 sensitization among Bet v 1-positive patients and clearly demonstrated that 96.4% of patients with specific IgE to Bet v 1 also had specific IgE to rMal d 1 at clinically relevant levels. Since primary sensitization to apple is uncommon, it indicates strongly that birch pollen-food allergy syndrome could be of clinical importance among Chinese birch pollen allergy patients.
Soy allergy conventionally is characterized by IgE sensitization to storage proteins like Gly m 5, Gly m 6 (Holzhauser et al., 2009; Ito et al., 2011) , or Gly m 8 that are 2S albumins (Ebisawa et al., 2013) . The association between birch and soy allergy was first reported by Kleine-Tebbe et al. (2002) describing that patients with birch pollen allergy had allergic reactions to a soy-containing dietary product. In contrast to conventional soy allergy, tree pollen-related Gly m 4 allergy seems to be associated with reactions only to mildly processed soy (often soy milk) (Kosma et al., 2011; Fukutomi et al., 2012) , which is possibly related to the structural stability of Gly m 4. The amino acid sequence identity between Gly m 4 and Bet v 1 is 53% and allergic reactions after ingestion of soy bean have been shown to be caused by Bet v 1-specific IgE antibodies cross-reacting with Gly m 4 (Kleine- Tebbe et al., 2002) . In our study, close to 80% of birch allergic patients were also sensitized to rGly m 4. The clinical relevance of this finding needs to be established since IgE sensitization to both Bet v 1 and Gly m 4 can cause severe pollen-food allergy syndrome reactions, although not all Gly m 4-sensitized patients show clinical symptoms of soy allergy (Mittag et al., 2004) . Unfortunately, lack of detailed patient clinical history and profiles in this retrospective study as well as access to specific food-allergen reagents prevented further investigation and more detailed studies are needed addressing the prevalence and clinical manifestations of pollen-food allergy syndrome in China.
In summary, the prevalence of birch polleninduced allergy seems to be high during the pollen season in northern China. Similar to other populations, the majority of Chinese birch allergic patients are sensitized to the major birch pollen allergen Bet v 1. A relatively large amount of patients (17.6%) are IgEsensitized to birch pollen allergen(s) other than Bet v 1.
The high prevalence of specific IgE to rMal d 1 and rGly m 4 among Bet v 1-sensitized patients indicates that birch pollen-food allergy syndrome may be of clinical relevance in China and require more detailed investigation. Evaluation of pollen-food allergy syndrome and allergen avoidance recommendations should be considered in the clinical management and recommendations to patients with confirmed birch pollen allergy.
